The selective antagonist of α7 nAChR can inhibit the proliferation, angiogenesis, and metastasis of nicotine in human NSCLC, which is considered as a potential anticancer agent [10,16,40,41,42,43]. The gene discussed is CHRNA7; the disease is non-small cell lung carcinoma.